Abstract 2749: iPSC-derived natural killer cells as the front-runner program of the EVO<i>cells</i> Oncology platform: From inception to translational validation using patient samples

Authors: Michael Esquerré, Audrey Holtzinger, Mélanie Pichery, Stefanie Pfaender, Saniye Yumlu, Mandy Richter, Delphine Betous, Oriane Bombarde, Mylène Gador, Nadja Sailer, Michael Paillasse, Loïc Ysebaert, Fabien Despas, Matthias Austen, Andreas Scheel, Markus Dangl

Published: 2022-06-15

DOI: 10.1158/1538-7445.am2022-2749

Source: Full article